KATHLEEN PUGH: Open Payments
NPI 1245736685 · ANDALUSIA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$461 in 23 payments from 14 companies in 2025. Trend: 2023 $1,036 · 2024 $1,075 · 2025 $461
Food & beverage: $461
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $104 |
| ARRAY BIOPHARMA INC | 3 | $53 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
| Novartis Pharmaceuticals Corporation | 2 | $37 |
| Lilly USA, LLC | 2 | $35 |
| Celgene Corporation | 2 | $33 |
| Merck Sharp & Dohme LLC | 1 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $21 |
| BeiGene USA, Inc. | 1 | $21 |
Products named: VENCLEXTA, ELAHERE, BRUKINSA, BRAFTOVI, KISQALI, VERZENIO, REBLOZYL, KEYTRUDA.
Industry payments across AL — which companies pay providers there.
